u-There is evidence that posttraumatic ischemia is important in the pathogenesis of acute spinal cord injury (SCI). In the present study spinal cord blood flow (SCBF), measured by the hydrogen clearance technique, and motor and somatosensory evoked potentials (MEP and SSEP) were recorded to evaluate whether the administration of nimodipine and dextran 40, alone or in combination, could increase posttraumatic SCBF and improve axonal function in the cord after acute SCI. Thirty rats received a 53-gm clip compression injury on the cord at T-1 and were then randomly and blindly allocated to one of six treatment groups (five rats in each). Each group was given an intravenous infusion of one of the following over 1 hour, commencing 1 hour after SCI: placebo and saline; placebo and dextran 40; nimodipine 0.02 mg/kg and saline; nimodipine 0.02 mg/kg and dextran 40; nimodipine 0.05 mg/kg and saline; and nimodipine 0.05 mg/kg and dextran 40.
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HERE is evidence that spinal cord injury (SCI) in
the acute phase is caused by two separate mechanisms: the initial mechanical damage and secondary changes due to vascular or biochemical effects. 2"6"36"37 Indeed, measurements of spinal cord blood flow (SCBF) 2"9"12"18"19"35"47 as well as microangiographic studies 4"H'47 have shown ischemia at and extending away from the injury site. With recording of SCBF and motor and somatosensory evoked potentials (MEP's and SSEP's) from the cord with intraspinal microelectrodes, Fehlings, et al., ~'~ recently characterized the relationships among the severity of SCI, the extent of posttraumatic cord ischemia, and the resultant changes in axonal function. Their data showed that the reduction in posttraumatic SCBF varied as a linear function of injury severity and that axonal dysfunction after SCI was related both to the force of cord injury and to the degree of ischemia. These data suggested that it may be possible to improve axonal function after SCI by increasing the posttraumatic SCBF. To date, this hypothesis has not been validated.
There is considerable evidence that Ca ++ ions play a key role in the pathogenesis of posttraumatic ischemia and ischemic cell death. ~' 5 For example, ischemic depolarization of cell membranes is associated with an intracellular shift of Ca ++ which promotes smooth-muscle contraction and vasospasm, impairs mitochondrial function, and enhances the production of vasoactive prostanoids. 2~ Nimodipine, a dihydropyridine calcium channel blocker, has recently been shown to increase posttraumatic SCBF, '~ although the effect on recovery of posttraumatic axonal function is not known. Guha, et al., ~" reported that the effect of nimodipine on postinjury SCBF required the concomitant administration of the vasopressor adrenaline to correct posttraumatic hypotension and to prevent further lowering of the mean arterial blood pressure (MABP) by peripheral vasodilatation. However, there is evidence that catecholamines may exacerbate neuronal injury after cord trauma, 2~3' hence an alternative method of maintaining the MABP would theoretically enhance the possibility of achieving recovery of axonal function. Recently, Wallace and Tator 48 reported that hypervolemic hemodilution with dextran 40 significantly increased MABP and SCBF after SCI in rats; therefore, dextran 40 would appear to be a suitable adjunct to nimodipine. In the present study, the combination of MEP and SSEP recordings and SCBF measurement has been used to examine whether the administration of nimodipine and dextran 40, alone or together, could increase posttraumatic SCBF and improve axonal function in the cord after acute experimental SCI.
Materials and Methods
Operative Procedures
Thirty adult Wistar rats* (mean weight __ standard error of the mean (SEM): 341 _+ 22 gm) were anesthetized by intraperitoneal injection of 75 mg/kg a-chloralose and 525 mg/kg urethane. After tracheostomy and insertion of bilateral femoral artery and vein catheters, a right parietal craniectomy was performed to expose the hindlimb sensorimotor cortex. ~' 2~ A laminectomy was made from C-6 to T-2, and each rat received a 1-minute extradural clip compression injury 34 of the cord at T-1 with a modified aneurysm clip? exerting a force of 53 gm, an injury which causes complete paraplegia. 27 Neuromuscular blockade was accomplished with intravenous pancuronium bromide (0.6 mg every hour) and the rats were mechanically ventilated and maintained by a 2:1 mixture of oxygen and nitrous oxide. The MABP, electrocardiogram, rectal temperature, hematocrit, and arterial blood gas pressures were monitored. The temperature was maintained at 37 ~ to 38~ with a heating pad, the arterial blood gases were maintained in a physiological range (pO~ > 100 mm Hg; pCO2 > 35 to 45 mm Hg), and the pH was held steady at 7.35 to 7.45.
Measurement of Spinal Cord Blood Flow
The SCBF was measured by the hydrogen clearance technique using a microcomputer-based recording system. 32 Platinum-iridium microelectrodes with a 10-um tip diameter were stereotactically inserted into the dorsal column of the cord, 0.5 mm lateral to the midline, at T-1 (injury site), C-6, and T-10 to a depth of 500 * Rats obtained from Charles River Canada, Inc., St. Constant, Quebec, Canada.
# Modified aneurysm clip manufactured by Walsh Manufacturing Co., Ltd., Oakville, Ontario, Canada. #m. The SCBF was recorded from these sites 1 hour before and at 1, 2, 3, and 4 hours after SCI (Fig. 1) . Linear regression was used on-line to compare the presaturation polarographic baseline level with the desaturation baseline level. Flows with a drift in baseline measurement of more than 5% were discarded. The initial slope index method 23 was used to calculate the SCBF from the logarithmically transformed desaturation curves.
Motor and Somatosensory Evoked Potentials
The MEP's and SSEP's were recorded concomitantly with the SCBF (Fig. 1) 1 hour before and at 1, 2, 3, and 4 hours after SCI. The MEP's were elicited by applying anodal stimuli to the SMC via a 0.8-mm platinum ball electrode, referenced to an Ag/AgC1 disc electrode under the hard palate. The MEP's from the spinal cord (MEP-C) were recorded from two platinum-iridium microelectrodes stereotactically inserted to a depth of 500 um in the dorsal columns and 0.5 mm lateral to the dorsal vein; at T-10 the MEP's from the sciatic nerve (MEP-N) were recorded from a bipolar electrode on the left sciatic nerve. The stimulus parameters were: intensity 10 mA, pulse duration 50 usec, and presentation rate 8.2 Hz for the MEP-C; and intensity 30 mA, pulse duration 300 usec, and presentation rate 4.2 Hz for the MEP-N. A total of 512 MEP-C and 50 MEP-N responses were recorded at a bandwidth of 30 to 3000 Hz, averaged,z~ and replicated. The spinal evoked potential (SEP) recorded from the microelectrodes at T-10 and the SSEP recorded from the platinum electrode over the sensorimotor cortex were elicited by applying cathodal stimuli (intensity 10 mA, pulse duration 50 usec, and presentation rate 8.2 Hz) to the left sciatic nerve. A total of 1024 SEP and SSEP responses were recorded at a bandwidth of 30 to 3000 Hz, averaged, and replicated. The latency and amplitude of the evoked potential (EP) peaks were scored by two independent blinded observers using previously established criteria; v-m~' the scoring methodology used to label peaks is illustrated for the MEP-C and SSEP in Fig. 2 . The MEP-N and SEP peaks were labeled as positive (P) and negative (N) deflections in a manner similar to the SSEP.
Experimental Protocol
The experimental protocol is schematically shown in Fig. 1 . Following the preinjury recordings, the rats each received a 53-gm clip compression injury of the cord at T-1. The microelectrodes were removed just prior to injury and reinserted immediately thereafter. Following the postinjury recordings of SCBF and EP's, the rats were randomly and blindly assigned to one of the following groups (five animals in each): placebo and saline; placebo and dextran 40; nimodipine 0.02 mg/kg and saline; nimodipine 0.02 mg/kg and dextran 40; $ Signal averager, Model 8400, manufactured by Cadwell Laboratories Inc., Kennewick, Washington. nimodipine 0.05 mg/kg and saline; and nimodipine 0.05 mg/kg and dextran 40. Nimodipine was supplied as a 0.02% stock solution in a polyethylene glycol, ethanol, and water diluent. The stock solution was diluted with placebo (diluent alone) to obtain the appropriate concentrations of nimodipine. The infusion syringes were protected from light with aluminum foil, and a sodium vapor lamp was used during dilution and delivery of the drug due to the photosensitivity of nimodipine to normal light. 4~ Two Harvard infusion pumps were used to deliver a fixed volume of drug at a constant rate over 1 hour via separate femoral venous access sites: one pump for nimodipine or placebo (3.0 ml) and the second for dextran 40 or saline (7.0 ml). Postinfusion SCBF and EP recordings were made immediately following the infusion and at 1 and 2 hours after the cessation of drug delivery.
Effect of nimodipine and dextran on spinal cord injury in rats
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Histological Assessment and Quantitation o J Cord Hemorrhages
At the conclusion of the experiment, the microelectrode sites were electrolytically marked (10 uA direct current for 15 sec) and the rats were transcardially perfused with 10% formalin. Serial 8-urn cross sections of the injury site and electrode sites were stained with Luxol fast blue. The sections were examined to confirm the position of the microelectrodes and to quantitate the amount of hemorrhage at the injury site. For the latter, 130 consecutive cross sections through the injury site (a 1.04-mm segment of fixed cord) containing the maximum amount of hemorrhage were selected by microscopy, and quantitative evaluation was undertaken on every 10th section with an interactive image analysis systemw in a "blinded" fashion. The sections were displayed at x 25 magnification on a television screen by a camera interfaced to a photomicroscope and digitized to achieve a gray scale range of 0 to 255. A binary discrimination algorithm was created to interactively separate hemorrhagic from nonhemorrhagic tissue on the basis of their different levels of gray. The area of hemorrhage and the total cross-sectional area of each slice were quantitated from the digitized image. The volume of hemorrhage and the total volume of the cord were calculated from the 13 sections by means of an integration algorithm based on Simpson's theorum: 4~ Vx = ~ dx(AO + 4A1 + 2A2 + 4A3 + 2A4 + ... + 2An-2 + 4An-1 + An), where Vx = volume of cord or hemorrhage, dx = interval between sections = 80 urn, AO = area of first section analyzed, and n = 12.
Statistical Analysis
The data were evaluated in a blinded fashion and the treatment code was not broken until the conclusion of the statistical analysis. Interobserver differences in the analysis of the EP data were assessed by two-tailed paired t-tests. Each dependent measure was analyzed by multivariate analysis of variance (MANOVA) for 
Results
Physiological Parameters
The mean preinjury physiological parameters including the MABP (129 + 2.3 mm Hg), hematocrit (46.2% + 1.6%), heart rate (545 _+ 7 beats/min), pH (7.34 + 0.02), pO2 (168.6 + 5.8 mm Hg), and pCO2 (38.7 _ 0.6 mm Hg) were not significantly different (p > 0.05) among the groups (Table 1) 
Spinal Cord Blood Flow
The SCBF data recorded from the injury site at T-l, adjacent to the injury site at C-6, and distal to the injury The preinjury SCBF measured from the cord at C-6 was similar among the groups (mean 51.88 + 3.72 ml/ 100 gm/min; F = 0.33, df = 5,24, p > 0.05). Based on the MANOVA, the SCI at T-1 and drug infusion significantly affected the SCBF at C-6 (F = 26.11, df = 4,20, p < 0.0001). Indeed, after SCI, there was a significant decline in the SCBF at C-6 to 30.43 + 1.99 ml/ 100 gm/min (F = 41.79, df = 1,23, p < 0.0001), although the SCBF at C-6 remained similar among the treatment groups (F = 0.80, df = 5,24, p > 0.05). Furthermore, MANOVA showed that drug infusion resulted in a significant increase in the SCBF at C-6 (F = 7.34, df = 1,23, p < 0.03). Two-way ANOVA revealed that the SCBF at C-6 was significantly increased in the groups treated with placebo and dextran 40 (46.66 + 9.70 ml/100 gm/min; F = 4.05, df = 4,16, p < 0.02), test revealed a significant reduction in the SCBF at C-6 at 1 hour (24.09 _+ 1.85 ml/100 gin/rain) and 2 hours (21.25 _+ 2.32 ml/100 gm/min) following termination of the infusion in all groups.
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The preinjury SCBF at T-10 (mean 56.96 + 4.73 ml/ 100 gm/min) was similar in all treatment groups (F = 0.66, df = 5,24, p > 0.05). Although the SCBF at T-10 tended to be lower after cord injury due to the decline in MABP, this change was not significant (p > 0.05) in any group. Indeed, two-way ANOVA showed that the SCBF at T-10 did not change significantly (p > 0.05) in any group at any point during the course of the experiment, with the notable exception of the group that received nimodipine 0.02 mg/kg and dextran 40. In the latter group, the postinfusion SCBF at T-10 2 hours after injury (81.49 + 8.45 ml/100 gm/min) was significantly greater than at other times in the experiment (F = 5.00, df = 4,16, p < 0.02).
Electrophysiological Analysis
The interobserver differences in the scoring of the latency (t = 1.22, p > 0.05) and amplitude (t = 1.01, p > 0.05) of the EP peaks were not significant. Representative EP tracings from a control rat treated with placebo and saline and a rat treated with the combination of nimodipine 0.02 mg/kg and dextran 40 are presented in Fig. 6 upper and lower, respectively. Preinjury, the latency of each MEP-C peak was similar (p > 0.05) among the six groups. With the labeling system shown in (Fig. 6) . Oneway ANOVA revealed that infusion of nimodipine 0.02 mg/kg and dextran 40 was associated with a significant recovery of the P~ (F = 4.98, df = 5,24, p < 0.01) and N~ (F = 2.72, df = 5,24, p < 0.05) peaks, whereas no improvement was seen in the other groups. Furthermore, the improvement in the amplitude of P] (F = 5.38, df = 5,24, p < 0.005) and N~ (F --4.42, df = 5,24, p < 0.02) persisted at 1 hour following infusion but was no longer apparent at 2 hours after the conclusion of drug administration (P~: F = 0.91, df = 5,24, p > 0.05; N~: F = 1.09, df = 5,24, p > 0.05).
Preinjury, the latency and amplitude of each SSEP peak were not significantly different among the six treatment groups. Multivariate analysis showed that the amplitude of these peaks changed significantly over the course of the experiment (P,: F = 14. (Fig. 9) , whereas no improvement was seen with the other treatment combinations. Two-way ANOVA showed that the P2 amplitude remained significantly increased (F = 12.70, df = 4,16, p < 0.001) at 1 and 2 hours following infusion, whereas the N2 amplitude was significantly increased at 1 hour (F = 24.75, df = 4,16, p < 0.001) but not at 2 hours postinfusion. One-way ANOVA revealed that the latency and amplitude of the SEP peaks were similar (p > 0.05) among the six groups. Furthermore, multivariate analysis of the SEP's revealed that neither their latency nor their amplitude changed significantly (p > 0.05) over the course of the experiment, thus confirming that the EP changes described above reflect specific changes in axonal function at the injury site and not changes in axonal physiology due to an unstable experimental preparation.
Multiple regression revealed that the changes in axonal function were significantly correlated with the changes in SCBF. Indeed, the amplitude of the d (F = 90.47, df = 1,149, p < 0.0001) (Fig. 10) and i2 (F = 3.62, df = 1,149, p < 0.05) peaks of the MEP-C and 
Histological Assessment and Quantitation of Cord Hemorrhages
Examination of the electrode tracks revealed that the tips of the microelectrodes were located at the base of the dorsal columns, near the gray/white matter interface in all cases. The C-6 electrode tracks were located 6.1 _+ 0.4 mm rostral to the tracks in the cord at T-1. The results of the quantitative assessment of the volume of hemorrhage in a 1.04-mm section of cord encompassing the injury site are summarized in Table 2 . The total cord volume ranged from 6.59 + 0.50 to 8.97 + 1.13 cu mm and was not significantly different (F = 2.14, df = 5,24, p > 0.05) among the groups. Furthermore, neither the total volume of hemorrhage at the injury site (F = 2.12, df = 5,24, p > 0.05) nor the percent hemorrhage by volume (F = 2.12, df = 5,24, p > 0.05) varied significantly among treatment groups, indicating that pharmacological improvement of posttraumatic SCBF did not exacerbate the degree of hematomyelia.
Discussion
The present investigation provides quantitative evidence supporting the hypothesis that reversal of posttraumatic ischemia can promote recovery of axonal function after acute SCI. Infusion of nimodipine at 0.02 mg/kg in combination with dextran 40 significantly improved posttraumatic SCBF and axonal function as assessed by MEP's and SSEP's, a technique which accurately reflects axonal function in the descending and ascending tracts of the cord, respectively, 71~ and is highly correlated with clinical neurological function. ~ Moreover, the improvement in axonal function attained with nimodipine and dextran was highly correlated with the improvement in SCBF (Fig. 10) .
Within 1 hour after trauma, there was a marked decline in SCBF both at and adjacent to the injury site, similar to the findings of others. ~~'~3~'47 For example, Sandler and Tator ~'~7 demonstrated that the area of ischemia spread rostraUy and caudally from the point of injury and resulted in areas of spinal cord infarction up to 2 cm away. Senter and Venes, 42 using the hydrogen clearance technique, also reported decreased SCBF at and 1 cm remote from the site of trauma.
The MABP shows a characteristic response pattern to major cervical cord injury with a brief initial hypertensive peak ~'4s followed by a sustained period of posttraumatic hypotension (Table 1) . Because the injured cord has impaired autoregulation, 43 it has been recommended that posttraumatic hypotension in patients should be corrected in order to maximize neuronal recovery, 4546 but the experimental or clinical proof of this practice is lacking. Although the administration of saline, dextran, and nimodipine 0.02 mg/kg with dextran 40 increased the postinjury MABP significantly (Table 1 and Fig. 11 ), only the latter treatment resulted in a significant increase in SCBF at T-1 (Figs. 3 and  11 ), indicating that correction of posttraumatic hypotension alone is insufficient to restore SCBF after SCI. It should be emphasized that the beneficial effect of nimodipine on posttraumatic ischemia was critically dependent on the maintenance of an adequate MABP by dextran 40, confirming the results of Guha, et al. ~ (Fig. 11) . The ability of the normal cord to autoregulate in the face of decreased MABP is evidenced by the lack of a significant change in the SCBF at T-10 after cord injury. Indeed, only the administration of nimodipine 0.02 mg/kg and dextran 40 significantly increased the SCBF at T-10 over preinjury levels.
The mechanisms by which nimodipine and dextran affect SCBF may be understood more clearly by referring to the Hagen-Poiseuille equation, 3~ which may be used to model blood flow in linear conductance vessels to a first approximation. Given a tube of length L and radius r with a pressure gradient of (P1-P2) across the length of the tube, then the laminar flow (Q) of a newtonian fluid of viscosity n is defined by:
The administration of dextran 40 resulted in hypervolemic hemodilution as evidenced by an increase in the MABP and a decrease in the hematocrit. Since hematocrit is an important determinant of blood Equation 1), the increased SCBF at C-6 with dextran 40 is readily explained and suggests that rheological factors contribute significantly to the pathogenesis of ischemia adjacent to the injury site, as has been postulated in cerebral ischemia? 1-53 In contrast, the infusion of dextran without nimodipine failed to improve SCBF at the injury site, indicating that nonrheological factors modulate posttraumatic ischemia at this location. Because blood flow varies as the fourth power of vessel radius (Equation 1), even small decreases in vessel caliber, due to a mechanism such as vasospasm, will drastically alter flow. Microangiographic studies have shown that posttraumatic ischemia is in part due to the impairment of structurally intact vessels to conduct blood, 41449 a phenomenon which has been termed posttraumatic vasospasm. '~ There is evidence that the mechanism of posttraumatic ischemia is critically dependent on the intracelluar influx of Ca ++, which promotes smooth-muscle contraction, initiates synthesis of vasoactive prostanoids, and promotes progressive microvascular lipid peroxidation. 120 Nimodipine, a blocker of voltage-sensitive Ca ++ channels, 4~ has previously been shown to produce vasodilatation in the brain and spinal cord. 19"26' 44 The ability of nimodipine to increase posttraumatic SCBF when the MABP was maintained at 80 to 90 m m Hg with dextran provides strong evidence that nimodipine counteracted a Ca++-mediated mechanism such as vasospasm.
There is evidence that nimodipine may also have a direct cytoprotective effect. For example, although the increase in SCBF with nimodipine 0.02 mg/kg and dextran 40 had waned by 2 hours postinfusion, the improvement in axonal function persisted (Fig. 7) . Furthermore, a transient recovery of the MEP-C occurred after treatment with nimodipine 0.05 mg/kg and dextran 40 despite the absence of a significant restoration of SCBF (Fig. 7) . It is therefore possible that nimodipine may have prevented or reversed further axonal injury by inhibiting Ca++-mediated cytotoxic processes such as impairment of mitochondrial function 22 or breakdown of membrane phospholipids. 2'~'5~ Indeed, nimodipine has been found to promote functional and metabolic recovery after cerebral ischemia in experimental animals 17254454 and improved clinical outcome in patients with acute stroke. 15, 16 Faden, et al., 3 on the other hand, reported that nimodipine at a dose of 0.06 or 0.12 mg/kg failed to promote histopathological or clinical neurological recovery 24 to 48 hours after an ischemic cord injury in rabbits. However, in the latter study neither SCBF nor MABP was measured and no adjuvant agents were used to maintain the MABP. Similarly, Ford and Maim ~3 reported that nimodipine failed to reverse SCI in cats, but they did not administer an adjuvant agent to maintain the MABP.
Quantitative assessment of the volume of hemorrhage at the injury site showed that the improvement in SCBF achieved with nimodipine and dextran did not exacerbate the extent of hematomyelia (Table 2) . Rawe, et al., 3~ examined the effect of hypertension on the degree of posttraumatic intramedullary hemorrhage in cats with the thoracic cord injured by the weight-drop technique: in animals with MABP raised to greater than 150 mm Hg by the administration of metaraminol, there was a significant increase in the extent of intramedullary hemorrhage. In the present experiment, the MABP in the group that received nimodipine 0.02 mg/ kg and dextran 40 was 88.4 mm Hg (Table 1) , and this may in part account for the lack of a significant change in the volume of hemorrhage at the injury site.
In conclusion, the administration of nimodipine at 0.02 mg/kg in combination with dextran 40 significantly increased posttraumatic SCBF and promoted a significant recovery of axonal function in the motor and sensory tracts of the cord. This study provides quantitative evidence that increasing the SCBF at the site of cord trauma can significantly improve the function of acutely injured spinal axons. Furthermore, these data strongly indicate that posttraumatic ischemia is of major importance in the pathogenesis of axonal dysfunction after acute cord injury and is reversible by pharmacological intervention. Further experiments to assess whether the improvement in function can be maintained for longer periods of time are required before the clinical applicability of these encouraging results can be determined.
